سامانه مدیریت نشریات علمی دانشگاه علوم پزشکی مشهد

Hayati, Hadi, Kebriaeezadeh, Abbas, Ehsani, Mohammad ali, Nikfar, Shekoufeh, Mehrvar, Azim. (1395). Cost-analysis of Treatment of Pediatrics Acute Lymphoblastic Leukemia based on ALL-BFM Protocol. , 4(9), 3381-3389. doi: 10.22038/ijp.2016.7370
Hadi Hayati; Abbas Kebriaeezadeh; Mohammad ali Ehsani; Shekoufeh Nikfar; Azim Mehrvar. "Cost-analysis of Treatment of Pediatrics Acute Lymphoblastic Leukemia based on ALL-BFM Protocol". , 4, 9, 1395, 3381-3389. doi: 10.22038/ijp.2016.7370
Hayati, Hadi, Kebriaeezadeh, Abbas, Ehsani, Mohammad ali, Nikfar, Shekoufeh, Mehrvar, Azim. (1395). 'Cost-analysis of Treatment of Pediatrics Acute Lymphoblastic Leukemia based on ALL-BFM Protocol', , 4(9), pp. 3381-3389. doi: 10.22038/ijp.2016.7370
Hayati, Hadi, Kebriaeezadeh, Abbas, Ehsani, Mohammad ali, Nikfar, Shekoufeh, Mehrvar, Azim. Cost-analysis of Treatment of Pediatrics Acute Lymphoblastic Leukemia based on ALL-BFM Protocol. , 1395; 4(9): 3381-3389. doi: 10.22038/ijp.2016.7370

Cost-analysis of Treatment of Pediatrics Acute Lymphoblastic Leukemia based on ALL-BFM Protocol

Journal of Pediatric Perspectives
مقاله 3، دوره 4، شماره 9 - شماره پیاپی 33، آذر 2016، صفحه 3381-3389    اصل مقاله (391.24 K)
شناسه دیجیتال (DOI): 10.22038/ijp.2016.7370
نویسندگان
Hadi Hayati1؛ Abbas Kebriaeezadeh* 1؛ Mohammad ali Ehsani2؛ Shekoufeh Nikfar1؛ Azim Mehrvar3
1Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, IR Iran.
2Department of Pediatric Hematology and Oncology, Bahrami Hospital, Tehran University of Medical Sciences, Tehran, IR Iran.
3MAHAK Pediatric Cancer Treatment and Research Center, Tehran, IR Iran.
چکیده
Background
Among all pediatric cancers acute lymphoblastic leukemia (ALL) is highly prevalent, butthe overall cost of ALL management is not well-known, there is a need to assess the Berlin-Frankfurt-Munster (BFM) protocol commonly used in ALL management in Iran. So, the aim of this study was to estimate direct and indirect costs of ALL treatment among children based on the ALL-BFM protocol from the societal perspective in Iran.
Materials and Methods
A retrospective study was conducted. All pediatric patients newly diagnosed with ALL and managed by the BFM protocol from 2010-2015 were included. Finally, total costs, including direct medical costs, direct non-medical costs and indirect costs were calculated.
Results
The total direct medical cost per patient for a complete treatment period was 15,026.6US dollars, the direct non-medical cost incurred was 1,688.9 USD and the indirect cost due to productivity loss was 932.3 USD.
Conclusion
Treatment of pediatrics ALL is less costly in Iran comparing other countries. So, physicians and policy makers and health care system administrators should devise an appropriate strategy to reduce the direct medical costs which have more economic burden special for hospitalization days and chemotherapy costs based on the findings.
کلیدواژه‌ها
Acute Lymphocytic Leukemia؛ ALL-BFM؛ Cost-analysis؛ Pediatrics
آمار
تعداد مشاهده مقاله: 2,952
تعداد دریافت فایل اصل مقاله: 1,837